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Introduction
Breast cancer is the leading cause of cancer deaths among women worldwide. While many risk factors 
for breast cancer are known, viral infection has emerged as a potential contributor to tumor 
development. Human Cytomegalovirus (HCMV) generally causes mild or asymptomatic infection; 
however, recent evidence links HCMV to breast cancer. Several studies have detected HCMV DNA 
and proteins in breast tumor biopsies. Of particular interest is the viral cytokine cmvIL-10, a potent 
immunosuppressive protein encoded by the HCMV UL111A gene, which promotes proliferation, 
migration, and invasion of breast cancer cells in culture (1, 2). Since HCMV is transmitted via human 
breast milk, we hypothesized that breast tumor cells could become infected and produce cmvIL-10. 
Here, we investigated whether breast tumor cells support productive virus infection. 
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Figure 2. Breast tumor cells permit HCMV entry regardless of ER/PR/HER2 Status. Breast tumor cells were exposed to 
HCMV clinical strain TB40/E-wildtype tagged with green fluorescent protein (GFP) for 72 hours and monitored for viral entry 
by fluorescence microscopy. All breast tumor cell lines exposed to HCMV were positive for viral entry as demonstrated by 
green fluorescence. NuFF cells exposed to HCMV were also positive for viral entry. Mock infected breast tumor cells and 
NuFF cells were all negative for viral entry as expected. Results indicate that viral entry occurs independent of ER/PR/HER2 
receptor interactions since all four breast tumor cell lines have distinct ER, PR, and HER2 receptor expression profiles. . 
Figure 3. Breast tumor cells exposed to HCMV express immediate-early, early, and late viral genes. RNA 
harvested from mock infected and infected breast tumor cells was reverse-transcribed to cDNA and analyzed for HCMV 
immediate-early, early, and late viral gene expression using RT-PCR. Mock infected breast tumor cells were negative for 
UL123 (immediate-early), UL54 (early), and UL111A (late) HCMV gene expression. Breast tumor cells exposed to 
HCMV were positive for UL123 (immediate-early), UL54 (early), and UL111A (late) HCMV gene expression. These 
results indicate that breast tumor cells support HCMV infection in vitro. 
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• Human breast tumor cells permit HCMV entry in vitro. This suggests that HCMV may enter 
human breast tumor cells in vivo. 
• Human breast tumor cells support immediate-early, early, and late viral gene expression in vitro.
This supports the hypothesis that breast tumor cells support HCMV infection, and suggests 
support for in vivo infection of breast tumor cells. 
• HCMV proteins are expressed by breast tumor cells in vitro, providing further support for the 
hypothesis that breast tumor cells support HCMV infection. 
• Infectious viral progeny are produced during infection of human breast tumor cells, which 
suggests that breast tumor cells are productively infected. 
• Future work will include additional detection of cmvIL-10 by ELISA and investigation of the 
impacts of HCMV infection on breast tumor cell surface receptor expression patterns
Viral progeny are produced during infection of breast tumor cells
Figure 5. Infected breast tumor cells produce infectious viral progeny. Supernatant (SN) from mock infected 
and infected breast tumor cells was harvested and used to treat NuFF cells in order to determine if infected breast 
tumor cells produce infectious viral progeny. SN from mock infected and infected NuFF cells was used as a control. 
Fluorescence microscopy results demonstrated that NuFF cells treated with SN from infected MCF-7 or MDA-MB-
231 cells were positive for infection as indicated by areas of green fluorescence. NuFF cells treated with SN from 
infected NuFF cells were positive for infection as well. NuFF cells treated with SN from mock infected MCF-7, MDA-
MB-231 or NuFF cells were all negative for infection as indicated by lack of fluorescence. These results demonstrate 
that HCMV-infected breast tumor cells are producing infectious viral progeny and also suggest that these infected 
breast tumor cells are undergoing lytic (productive) viral infection. 
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2. Virus infection, viral entry assays, and analysis of viral gene and protein expression. Breast 
tumor cells were infected with the HCMV clinical strain TB40/E-wildtype, which is tagged with green 
fluorescent protein (GFP). NuFF cells were used as a control (3). RNA was extracted and cDNA 
synthesized. Viral gene expression was analyzed using polymerase chain reaction (PCR).  Additional 
mock infected and infected breast tumor cells were harvested for analysis of viral protein expression by 
Western blot.  NuFF cells were used as a control for infection. 
3. Virus infectivity assays. NuFF cells were treated with supernatant (SN) harvested from mock infected 
and HCMV-infected MCF-7 or MDA-MB-231 breast tumor cells. Mock infected and HCMV-infected NuFF 
SN was used as an additional control. Cells were monitored for signs of infection for 5 days using 
fluorescence microscopy. 
Figure 1. HCMV-infected breast tumor cells may serve as the source of cmvIL-10 in the tumor 
microenvironment. Breast tumor cells exposed to HCMV become infected and secrete cmvIL-10 into the 
tumor microenvironment. The cmvIL-10 protein secreted by HCMV-infected breast tumor cells binds the 
IL-10R on nearby breast tumor cells and initiates modulation of expression of immune recognition 
receptor proteins and immune effector molecules. 
HCMV-infected breast tumor cells express viral proteins
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Figure 4. HCMV-infected breast tumor cells express HCMV proteins. Lysates from mock infected or infected breast tumor cells 
were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotted using plasma from a representative
HCMV-positive donor. Lysates from HCMV-infected breast tumor cells showed a significantly stronger response to the HCMV-positive
patient serum as compared to the lysates from mock infected breast tumor cells. Lysates from mock infected and infected NuFF cells 
were run as a control for infection status. The IE1 protein can be seen in the infected cell lysates at 78 kDa, while the IE2 protein can 
be seen at 60 kDa. The cmvIL-10 protein can be seen in the infected cell lysates at 20 kDa. No viral proteins were detected in mock 
infected cell lysates. This data indicates that HCMV proteins are expressed by infected breast tumor cells. In combination with the viral 
entry and gene expression data these results provide additional supporting evidence that breast tumor cells support HCMV infection in 
vitro.
Table 1. Representative breast tumor and fibroblast cell lines used. 
1. Cell Lines. Four human breast tumor cell lines were used, each with a a unique expression profile for 
the key receptors estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth 
factor receptor 2 (HER2). Additionally, each cell line is representative of a diagnostic tumor classification. 
Neonatal human foreskin fibroblasts (NuFF) cells were used  as a control (Table 1). 
* NuFF = Neonatal human foreskin fibroblasts, not breast tumor cells. NuFF cells used 
as a control for infection.
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